What happened
FDA posted Haleon’s January 24, 2024 announcement of a voluntary consumer-level recall of eight lots of Robitussin Honey CF Max Day Adult and Nighttime Adult cough syrups because of microbial contamination. Haleon stated that affected products could potentially cause severe or life-threatening infections in immunocompromised individuals, while infections requiring medical intervention could not be completely ruled out in other consumers. No related adverse events had been reported at the time of the announcement. Haleon notified distributors and customers, provided return instructions, and advised consumers to stop use immediately. The FDA page now states that the recall has been completed and FDA has terminated it.
Why it matters
From a GMP and pharmaceutical manufacturing perspective, a multi-lot recall for microbial contamination may warrant attention to microbiological and contamination controls for finished liquid drug products. The consumer-level action and distributor return instructions also underscore the relevance of lot traceability and effective recall execution. The source identifies the contamination reason and affected lots but does not describe a root cause, manufacturing investigation, or corrective and preventive actions.
Key topics: Eight recalled Robitussin cough syrup lots, Microbial contamination and infection risk, Completed and terminated consumer-level recall